CME Presentations
TNBC
A Changing Approach to TNBC Management: Patients as Partners in Care
Speakers: Tiffany Traina, MD, FASCO, Vice Chair, Oncology CareStephanie Walker, Retired RN living with MBC de novo since July 2015Gregory Gregory Vidal, MD, PhD, Medical Oncologist Duration: 60 minutes
Presented on: June 29, 2023
Multiple Myeloma
Placing Bispecific Antibodies in the Treatment Landscape for Heavily Pretreated Multiple Myeloma
Speakers: Attaya Suvannasankha, MD, Associate Professor, Clinical MedicineHans Lee, MD, Associate Professor, Department of Lymphoma/Myeloma Duration: 60 minutes
Presented on: September 21, 2023
Gastric Cancer
The Dawn of New Treatment Approaches for HER2‐negative Advanced Unresectable or Metastatic Gastric or GEJ cancers
Speakers: Manish A. Shah, MD, FASCO, Professor of MedicineZev Wainberg, MD, Professor of Medicine and Surgery Co-Director Duration: 60 minutes
Presented on: November 9, 2023
CLL QI
Cytogenetic Testing for Patients with CLL/SLL
Speakers: Nilanjan Ghosh, MD, PhD, Professor of Medicine and ChairDanielle Brander, MD, Assistant Professor of Medicine, Division of Hematologic Malignancies and Cellular Therapy Duration: 30 minutes
Presented on: December 20, 2023
Guideline Recommendations for the Front-line Setting
Speakers: Nilanjan Ghosh, MD, PhD, Professor of Medicine and ChairDanielle Brander, MD, Assistant Professor of Medicine, Division of Hematologic Malignancies and Cellular Therapy Duration: 30 minutes
Presented on: December 20, 2023
Guideline Recommendations for the Relapsed/Refractory Setting
Speakers: Matthew Davids, MD, MMSc, Director of Clinical Research and Associate Director of Chronic Lymphocytic Leukemia (CLL) Center, Division of LymphomaNicole Lamanna, MD, Professor of Medicine Duration: 30 minutes
Presented on: February 12, 2024
Patient Priorities for CLL Care
Speakers: Matthew Davids, MD, MMSc, Director of Clinical Research and Associate Director of Chronic Lymphocytic Leukemia (CLL) Center, Division of LymphomaNicole Lamanna, MD, Professor of Medicine Duration: 30 minutes
Presented on: February 12, 2024
Management of HER2+ mCRC
State‐of‐the‐Art Approaches for Biomarker Testing and Management of HER2+ mCRC
Speakers: Leonard Saltz, MD, Professor of MedicineChristopher Lieu, MD, FASCO, Associate Director for Clinical Research Duration: 60 minutes
Presented on: December 8, 2023
Desmoid Tumors
The Promise of Emerging Therapies for Patients with Desmoid Tumors
Speakers: Richard Riedel, MD, Associate Professor of Medicine with TenureMrinal Gounder, MD, Associate Attending Professor Duration: 60 minutes
Presented on: December 12, 2023
NSCLC
Broadening Treatment for Patients with Newly Diagnosed NSCLC
Speakers: Julie Brahmer, Co-director, Upper Aerodigestive DepartmentHossein Borghaei, DO, MS Duration: 60 minutes
Presented on: December 4, 2023
Mantle Cell Lymphoma
A Growing Momentum in Untreated Mantle Cell Lymphoma
Speakers: Matthew Matasar, MD, Chief, Division of Blood Disorders Duration: 30 minutes
Presented on: December 18, 2023
GvHD and its Impact on Patients
Tackling Chronic GvHD: Patient‐centered Approaches
Speakers: Zachariah DeFilipp, MD, Director of BMT Clinical Research Duration: 30 minutes
Presented on: January 16, 2024
Young Adults with Hodgkin Lymphoma
Charting the Course for Pediatric and Young Adults with Hodgkin Lymphoma
Speakers: Lisa Roth, MD, Director, Pediatric OncologyMatthew Ehrhardt, MD, MS Duration: 60 minutes
Presented on: January 30, 2024
Clinical Updates in Chronic Graft vs Host Disease
Clinical Updates in Chronic Graft vs Host Disease and Applications for Academic and Community Practice
Speakers: Zachariah DeFilipp, MD, Director of BMT Clinical ResearchAndrew Rogers, Assistant Professor of Medicine Duration: 30 minutes
Presented on: February 13, 2024
Clinical Updates in Chronic Graft-versus-Host Disease and Applications for Academic and Community Practice
Speakers: Zachariah DeFilipp, MD, Director of BMT Clinical ResearchAndrew Rogers, Assistant Professor of Medicine Duration: 45 minutes
Presented on: March 20, 2024
CLL Managed Care
Value-Based Clinical Decision-Making for Chronic Lymphocytic Leukemia Managed in the Community Setting
Speakers: John Allan, Associate Professor of Clinical MedicineDr. Gary Owens, President Duration: 60 minutes
Presented on: February 21, 2024
Clinical Trial Diversity in Breast Cancer
Nurse-Patient Partnerships to Support Screening and Clinical Trial Diversity in Breast Cancer
Speakers: Melody Taylor, MSN, RN, CCM, Vice-PresidentMonique Gary, DO, MSc, FACS, Medical Director Duration: 60 minutes
Presented on: March 8, 2024
Application and Consideration of Treatment Strategies for Relapsed/Refractory MM
Application and Consideration of Treatment Strategies for Relapsed/Refractory MM
Speakers: Melissa AlsinaMonique Hartley-Brown, MD, MMSc, Attending Physician Duration: 60 minutes
Presented on: March 22, 2024